Literature DB >> 19369969

Progress and prospects: biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors.

A L Epstein1.   

Abstract

The last two years have seen significant advances in our understanding of the cellular innate responses elicited or activated by the entry of amplicon particles, which may, in part, explain the transient nature of transgene expression often observed in cells infected with helper-free amplicon stocks. At the technological level, the most consistent progress has been in strategies to enhance the stability of transgene cassettes, either through integration into host chromosomes or through the conversion of the amplicon genome into a replication-competent extrachromosomal element.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369969     DOI: 10.1038/gt.2009.42

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  9 in total

Review 1.  Gene therapy for the treatment of chronic peripheral nervous system pain.

Authors:  William F Goins; Justus B Cohen; Joseph C Glorioso
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

2.  Future viral vectors for the delivery of asymptomatic herpes epitope-based immunotherapeutic vaccines.

Authors:  Aziz Alami Chentoufi; Lbachir BenMohamed
Journal:  Future Virol       Date:  2010-09-01       Impact factor: 1.831

3.  Advances in Gene Delivery Systems.

Authors:  Kenya Kamimura; Takeshi Suda; Guisheng Zhang; Dexi Liu
Journal:  Pharmaceut Med       Date:  2011-10-01

4.  Human artificial chromosome (HAC) vector with a conditional centromere for correction of genetic deficiencies in human cells.

Authors:  Jung-Hyun Kim; Artem Kononenko; Indri Erliandri; Tae-Aug Kim; Megumi Nakano; Yuichi Iida; J Carl Barrett; Mitsuo Oshimura; Hiroshi Masumoto; William C Earnshaw; Vladimir Larionov; Natalay Kouprina
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

Review 5.  A new generation of human artificial chromosomes for functional genomics and gene therapy.

Authors:  Natalay Kouprina; William C Earnshaw; Hiroshi Masumoto; Vladimir Larionov
Journal:  Cell Mol Life Sci       Date:  2012-08-21       Impact factor: 9.261

6.  Herpesvirus vectors in gene therapy.

Authors:  Veijo Hukkanen
Journal:  Open Virol J       Date:  2010-06-18

Review 7.  Transformation-associated recombination (TAR) cloning for genomics studies and synthetic biology.

Authors:  Natalay Kouprina; Vladimir Larionov
Journal:  Chromosoma       Date:  2016-04-26       Impact factor: 4.316

8.  A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy.

Authors:  Selene Ingusci; Stefano Cattaneo; Gianluca Verlengia; Silvia Zucchini; Michele Simonato
Journal:  Epilepsy Curr       Date:  2019-02-12       Impact factor: 7.500

9.  Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells.

Authors:  Marie Soukupová; Silvia Zucchini; Pascal Trempat; Selene Ingusci; Coline Perrier-Biollay; Mario Barbieri; Stefano Cattaneo; Barbara Bettegazzi; Simonetta Falzoni; Hervé Berthommé; Michele Simonato
Journal:  Mol Ther Methods Clin Dev       Date:  2021-03-29       Impact factor: 6.698

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.